Related Experiment Video
Updated: Jul 19, 2026
09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Cerebrovascular disease and dementia
1Department of Psychiatry and Behavioral Sciences, Division of Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA. conyike1@jhem.jhmi.edu
International Review of Psychiatry (Abingdon, England)
|November 7, 2006
Summary
Cerebrovascular disease (CVD) causes significant psychiatric disability in older adults, primarily through dementia. Identifying risk factors and available treatments offers hope for prevention and management of vascular dementia.
Area of Science:
- Neurology
- Geriatrics
- Public Health
Background:
- Cerebrovascular disease (CVD) is a leading cause of psychiatric disability in the elderly.
- Dementia and cognitive impairment resulting from strokes are major contributors to this disability.
- Vascular dementia, while common, presents diagnostic challenges due to heterogeneity and co-occurrence with Alzheimer's disease.
Purpose of the Study:
- To describe the clinical features and natural histories of vascular dementia.
- To identify risk factors associated with vascular dementia.
- To explore available treatments and prevention strategies for vascular dementia.
Main Methods:
- Literature review and synthesis of existing research on cerebrovascular disease and dementia.
- Analysis of clinical features, pathological heterogeneity, and measurement challenges.
- Identification and categorization of risk factors, including hypertension, diabetes, hyperlipidemia, atherosclerosis-promoting conditions, and genetic mutations.
Main Results:
- Vascular dementia's frequency estimates vary due to its complex nature.
- Key risk factors identified include hypertension, diabetes mellitus, hyperlipidemia, and atherosclerosis.
- Emerging evidence suggests cholinesterase inhibitors may offer some efficacy in treatment.
Conclusions:
- Vascular dementia is a significant cause of elderly psychiatric disability, linked to cerebrovascular pathology.
- While not curable, vascular dementia can be managed through identified treatments and risk factor modification.
- Understanding risk factors provides opportunities for primary and secondary prevention, highlighting areas for future research.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...